Blog

TIME Recognises Drug Design for Global Health (dd4gh) Among 2026’s Best Inventions

The Drug Design for Global Health (dd4gh) project, developed by deepmirror in partnership with Medicines for Malaria Venture (MMV), has been named on TIME’s Best Inventions of 2026 list in the Social Impact category.

One AI to rule them all?

Is there a single AI model that can accurately predict whether a molecule would be a good drug against a disease?

deepmirror launches in Early Access

Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic drug discovery

deepmirror has been awarded an Innovate UK Biomedical Catalyst grant in collaboration with Nuclera

DeepMirror has successfully secured UKRI’s Biomedical Catalyst grant in collaboration with Nuclera.

Discovering potent and specific kinase inhibitors with the deepmirror App

Kinases are frequently dysregulated in disease and are an interesting yet challenging target against which to develop drugs. In this...

deepmirror has been awarded a UKRI grant in collaboration with BiologIC

deepmirror has successfully secured UKRI’s Innovative technologies for nucleic acid medicines manufacturing grant in collaboration with BiologIC

deepmirror has been awarded the UK Global Incubator Programme Grant

DeepMirror has been selected as one of only 8 innovative companies to join the Global Incubator Programme for AI in the MaRS Discovery...

Drugging the undruggable with PROTACs

What are PROTACs? How do they work? How are PROTACs optimised?

The Path to AI-driven Drug Discovery - Part 3: AI to learn from lab data

Read more about how AI can fast-track affinity optimisation during hit-to-lead and lead optimisation.

The Path to AI-driven Drug Discovery - Part 2: How is AI disrupting Drug Discovery?

Read more about the immense potential of AI in drug discovery.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.